IGF1R and hepatocellular carcinoma: Since IGF-1R and YAP were both upregulated in sorafenib-resistant hepatocellular carcinoma (HCC) [9], we investigated the interplay between IGF-1R and Hippo-YAP pathway in BCSCs.